Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer

Current Opinion in Neurobiology

Volumn 27, Issue , 2014, Pages 171-178

  Silver, Daniel J ^a   Silver, Jerry ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOCHONDROITIN SULFATE;

ANIMAL; BIOLOGICAL MODEL; CELL MOTION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; NEOPLASM; NERVE CELL; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHONDROITIN SULFATE PROTEOGLYCANS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEURONS;

EID: 84899152182     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.03.016     Document Type: Review

References (53)

1. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007, 54:1-18.
2. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000, 57:276-289.
3. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
4. Katoh-Semba R., Matsuda M., Kato K., Oohira A. Chondroitin sulphate proteoglycans in the rat brain: candidates for axon barriers of sensory neurons and the possible modification by laminin of their actions. Eur J Neurosci 1995, 7:613-621.
5. Snow D.M., Steindler D.A., Silver J. Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier. Dev Biol 1990, 138:359-376.
6. Cole G.J., McCabe C.F. Identification of a developmentally regulated keratan sulfate proteoglycan that inhibits cell adhesion and neurite outgrowth. Neuron 1991, 7:1007-1018.
7. Wu D.Y., Schneider G.E., Silver J., Poston M., Jhaveri S. A role for tectal midline glia in the unilateral containment of retinocollicular axons. J Neurosci 1998, 18:8344-8355.
8. Brittis P.A., Canning D.R., Silver J. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science 1992, 255:733-736.
9. Jhaveri S. Midline glia of the tectum: a barrier for developing retinal axons. Perspect Dev Neurobiol 1993, 1:237-243.
10. Becker C.G., Becker T. Repellent guidance of regenerating optic axons by chondroitin sulfate glycosaminoglycans in zebrafish. J Neurosci 2002, 22:842-853.
11. Chung K.Y., Taylor J.S., Shum D.K., Chan S.O. Axon routing at the optic chiasm after enzymatic removal of chondroitin sulfate in mouse embryos. Development 2000, 127:2673-2683.
12. Oakley R.A., Tosney K.W. Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo. Dev Biol 1991, 147:187-206.
13. Akita K., von Holst A., Furukawa Y., Mikami T., Sugahara K., Faissner A. Expression of multiple chondroitin/dermatan sulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance. Stem Cells 2008, 26:798-809.
14. Gates M.A., Thomas L.B., Howard E.M., Laywell E.D., Sajin B., Faissner A., Gotz B., Silver J., Steindler D.A. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J Comp Neurol 1995, 361:249-266.
15. Silver D.J., Steindler D.A. Common astrocytic programs during brain development, injury and cancer. Trends Neurosci 2009, 32:303-311.
16. Thomas L.B., Gates M.A., Steindler D.A. Young neurons from the adult subependymal zone proliferate and migrate along an astrocyte, extracellular matrix-rich pathway. Glia 1996, 17:1-14.
17. Bicknese A.R., Sheppard A.M., O'Leary D.D., Pearlman A.L. Thalamocortical axons extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent path. J Neurosci 1994, 14:3500-3510.
18. Hawthorne A.L., Wylie C.J., Landmesser L.T., Deneris E.S., Silver J. Serotonergic neurons migrate radially through the neuroepithelium by dynamin-mediated somal translocation. J Neurosci 2010, 30:420-430.
19. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995, 136:32-43.
20. Dillon G.P., Yu X., Bellamkonda R.V. The polarity and magnitude of ambient charge influences three-dimensional neurite extension from DRGs. J Biomed Mater Res 2000, 51:510-519.
21. Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J., Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 2012, 15:703-712.
22. Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.L., Bachoo R., Cannon S., Longo F.M., et al. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci 2011, 31:14051-14066.
23. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
24. Duan Y., Giger R.J. A new role for RPTPsigma in spinal cord injury: signaling chondroitin sulfate proteoglycan inhibition. Sci Signal 2010, 3:pe6.
25. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 1998, 20:156-167.
26. Bäumer B.E., Kurz A., Borrie S.C., Sickinger S., Dours-Zimmermann M.T., Zimmermann D.R., Bandtlow C.E. Nogo receptor homolog NgR2 expressed in sensory DRG neurons controls epidermal innervation by interaction with versican. J Neurosci 2014, 34:1633-1646.
27. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006, 7:617-627.
28. Grimpe B., Pressman Y., Lupa M.D., Horn K.P., Bunge M.B., Silver J. The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci 2005, 28:18-29.
29. Kuffler D.P., Sosa I.J., Reyes O. Schwann cell chondroitin sulfate proteoglycan inhibits dorsal root ganglion neuron neurite outgrowth and substrate specificity via a soma and not a growth cone mechanism. J Neurosci Res 2009, 87:2863-2871.
30. Condic M.L. Adult neuronal regeneration induced by transgenic integrin expression. J Neurosci 2001, 21:4782-4788.
31. Condic M.L., Snow D.M., Letourneau P.C. Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression. J Neurosci 1999, 19:10036-10043.
32. Gu W.L., Fu S.L., Wang Y.X., Li Y., Lu H.Z., Xu X.M., Lu P.H. Chondroitin sulfate proteoglycans regulate the growth, differentiation and migration of multipotent neural precursor cells through the integrin signaling pathway. BMC Neurosci 2009, 10:128.
33. Tan C.L., Kwok J.C., Patani R., Ffrench-Constant C., Chandran S., Fawcett J.W. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci 2011, 31:6289-6295.
34. Filous A.R., Evans T.A., Lang B.T., Silver J. Synaptic-like connections between dystrophic axons and NG2+ cells: another reason for regeneration failure after spinal cord injury. Society for Neuroscience Annual Meeting 2013.
35. Ramon Cajal S. Degeneration and Regeneration of the Nervous System, vol. 2 1928, Haffner Publishing Co, New York, NY, USA.
36. Lang B.T., Cregg J.M., DePaul M.A., Filous A.R., Tran A.P., Li S., Evans T.A., Busch S.A., Silver J. Non-invasive systemic modulation of the CSPG receptor PTPσ promotes locomotor and urinary recovery following severe contusive spinal cord injury. Society for Neuroscience Annual Meeting November 9-13 2013.
37. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J Neurosci 1994, 14:4716-4730.
38. Tan A.M., Zhang W., Levine J.M. NG2: a component of the glial scar that inhibits axon growth. J Anat 2005, 207:717-725.
39. Ughrin Y.M., Chen Z.J., Levine J.M. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J Neurosci 2003, 23:175-186.
40. Busch S.A., Horn K.P., Cuascut F.X., Hawthorne A.L., Bai L., Miller R.H., Silver J. Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci 2010, 30:255-265.
41. Busch S.A., Horn K.P., Silver D.J., Silver J. Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci 2009, 29:9967-9976.
42. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009, 10:9-22.
43. Sapieha P.S., Duplan L., Uetani N., Joly S., Tremblay M.L., Kennedy T.E., Di Polo A. Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol Cell Neurosci 2005, 28:625-635.
44. Fry E.J., Chagnon M.J., Lopez-Vales R., Tremblay M.L., David S. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010, 58:423-433.
45. Jaworski D.M., Kelly G.M., Piepmeier J.M., Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 1996, 56:2293-2298.
46. Zhang H., Kelly G., Zerillo C., Jaworski D.M., Hockfield S. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 1998, 18:2370-2376.
47. Silver D.J., Siebzehnrubl F.A., Schildts M.J., Yachnis A.T., Smith G.M., Smith A.A., Scheffler B., Reynolds B.A., Silver J., Steindler D.A. Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J Neurosci 2013, 33:15603-15617.
48. Varga I., Hutoczki G., Szemcsak C.D., Zahuczky G., Toth J., Adamecz Z., Kenyeres A., Bognar L., Hanzely Z., Klekner A. Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma. Pathol Oncol Res 2012, 18:413-420.
49. Muller S., Kunkel P., Lamszus K., Ulbricht U., Lorente G.A., Nelson A.M., von Schack D., Chin D.J., Lohr S.C., Westphal M., et al. A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene 2003, 22:6661-6668.
50. Viapiano M.S., Bi W.L., Piepmeier J., Hockfield S., Matthews R.T. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res 2005, 65:6726-6733.
51. Arslan F., Bosserhoff A.K., Nickl-Jockschat T., Doerfelt A., Bogdahn U., Hau P. The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. Br J Cancer 2007, 96:1560-1568.
52. Viapiano M.S., Hockfield S., Matthews R.T. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 2008, 88:261-272.
53. Hu B., Kong L.L., Matthews R.T., Viapiano M.S. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 2008, 283:24848-24859.